Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$392K Sell
5,310
-521
-9% -$39.2K 0.16% 82
2020
Q1
$428K Sell
5,831
-212
-4% -$16.7K 0.21% 75
2019
Q4
$524K Sell
6,043
-603
-9% -$49.5K 0.21% 72
2019
Q3
$534K Buy
6,646
+4
+0.1% +$321 0.23% 70
2019
Q2
$531K Buy
6,642
+82
+1% +$6.28K 0.24% 68
2019
Q1
$521K Buy
6,560
+71
+1% +$5.31K 0.24% 65
2018
Q4
$473K Buy
6,489
+988
+18% +$69.7K 0.24% 66
2018
Q3
$372K Sell
5,501
-130
-2% -$8.28K 0.17% 91
2018
Q2
$326K Buy
5,631
+550
+11% +$31K 0.16% 96
2018
Q1
$264K Sell
5,081
-266
-5% -$14.4K 0.13% 108
2017
Q4
$287K Buy
+5,347
New +$296K 0.13% 102

Other funds holding MRK

TrueWealth LLC's MRK Position: Q2 2020 in Review

TrueWealth LLC reduced its Merck (MRK) stake by 8.9% in Q2 2020, selling an estimated $39.2K and leaving 5,310 shares worth $392K. The position accounts for 0.16% of the portfolio, ranked #82.

TrueWealth LLC first reported a position in MRK in Q4 2017 and has held it in 11 quarters since. The position peaked at $534K in Q3 2019. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • TrueWealth LLC held 5,310 shares of Merck worth $392K as of Q2 2020.
  • TrueWealth LLC sold 521 Merck shares in Q2 2020, an estimated $39.2K.
  • Merck made up 0.16% of TrueWealth LLC's portfolio in Q2 2020, its #82 holding.
  • TrueWealth LLC first reported a position in Merck in Q4 2017 and has held it in 11 quarters since.
  • TrueWealth LLC's Merck position peaked at $534K in Q3 2019.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.